Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP626319.RACtVH18ipVK5VVGcF22c8lh4z4RJAC6JHFcsjxp9ksaU130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626319.RACtVH18ipVK5VVGcF22c8lh4z4RJAC6JHFcsjxp9ksaU130_provenance.
• NP763063.RAu2GYTywEdpu3MDcaYwId0xToWskpclexTxWdRBsDnzc130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763063.RAu2GYTywEdpu3MDcaYwId0xToWskpclexTxWdRBsDnzc130_provenance.
• NP564177.RAbFfGMGTtnI0myqr_dbLQx48aYPyytr_SgXMk17vfKpU130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564177.RAbFfGMGTtnI0myqr_dbLQx48aYPyytr_SgXMk17vfKpU130_provenance.
• NP265612.RADzlxx-ktnP50SvpTGwOJ15dcnSsberH_eooT0UlOTjI130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265612.RADzlxx-ktnP50SvpTGwOJ15dcnSsberH_eooT0UlOTjI130_provenance.
• NP819392.RAmsbXWBsyrUxiFqpfRKKkPaJDSSBOlNNriEtaLvYxBPk130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819392.RAmsbXWBsyrUxiFqpfRKKkPaJDSSBOlNNriEtaLvYxBPk130_provenance.
• NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857740.RAjtkeSRBjxFGL93cEAPwJC86zYhY-zdK2au5oOWnpsM8130_provenance.
• NP788953.RAVGx4upx_UNoZOstpAa2Xyx0LMekfYbSgard2qQ4OG04130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788953.RAVGx4upx_UNoZOstpAa2Xyx0LMekfYbSgard2qQ4OG04130_provenance.
• NP159459.RAGsgZEuCGmcbxdvliIgpLYsuiaS1OvRr8ORhtYbc-zP4130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP159459.RAGsgZEuCGmcbxdvliIgpLYsuiaS1OvRr8ORhtYbc-zP4130_provenance.
• NP315864.RAESNz3a5mPWtk-trv9jEX_48UrdWbbe9aXAablZUc7uE130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315864.RAESNz3a5mPWtk-trv9jEX_48UrdWbbe9aXAablZUc7uE130_provenance.
• NP819440.RA3uqUWNum86FFCtaBGWVKKoYdj3f6K2Zq9CDllSEmhyg130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819440.RA3uqUWNum86FFCtaBGWVKKoYdj3f6K2Zq9CDllSEmhyg130_provenance.
• NP929939.RAyjGpjw3acP85SPiA5zCazyZWotlj-XFhrDG3ibJNKv8130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929939.RAyjGpjw3acP85SPiA5zCazyZWotlj-XFhrDG3ibJNKv8130_provenance.
• NP539873.RATBRECpiZJMIKmp5Zkb27XAptXTe9IyL7HmEEi--MwKk130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539873.RATBRECpiZJMIKmp5Zkb27XAptXTe9IyL7HmEEi--MwKk130_provenance.
• NP661019.RAWloPh8bALEEP5VmmP_0Pa27AliDbJHzsK9alKGGSQhc130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661019.RAWloPh8bALEEP5VmmP_0Pa27AliDbJHzsK9alKGGSQhc130_provenance.
• NP833213.RAQLLkzwpG7KxzPrvs8EgcbeJgH2XajLMmo5vMbISTGno130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833213.RAQLLkzwpG7KxzPrvs8EgcbeJgH2XajLMmo5vMbISTGno130_provenance.
• NP651881.RAOWHSKdoimbiueCJ6UnXxRfAUMlFJmlPzQuG-AqJxtyc130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651881.RAOWHSKdoimbiueCJ6UnXxRfAUMlFJmlPzQuG-AqJxtyc130_provenance.
• assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP664010.RATXgPQFjrIdsYgW-bbt7K_lSGYPgeoGWwal6LZPHj2bw130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664010.RATXgPQFjrIdsYgW-bbt7K_lSGYPgeoGWwal6LZPHj2bw130_provenance.
• NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_provenance.
• NP664009.RAn3c4DkvWAbItcHoWsAe8j3Y6TzT0ZdN6p3Sq4-wTSDA130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664009.RAn3c4DkvWAbItcHoWsAe8j3Y6TzT0ZdN6p3Sq4-wTSDA130_provenance.
• NP664011.RAinAI30MrAPjiwMsUodl1HKGUeHQOa9vTaikyAYL_-2g130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664011.RAinAI30MrAPjiwMsUodl1HKGUeHQOa9vTaikyAYL_-2g130_provenance.
• NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_provenance.
• NP531523.RA9f8wfayMY0p-0gM4I7YpVAhvjyg6ZB5-3eeDPvX5M2E130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531523.RA9f8wfayMY0p-0gM4I7YpVAhvjyg6ZB5-3eeDPvX5M2E130_provenance.
• NP539787.RAxu_UdNSRhz57c48t8JiyX7Bp1iJJZs4HwkufhZzIP98130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539787.RAxu_UdNSRhz57c48t8JiyX7Bp1iJJZs4HwkufhZzIP98130_provenance.
• NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_provenance.
• NP664012.RA6l48a8yMLxDksMX6SP8SSdU6koup83S5ldYDHQ0x8BQ130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664012.RA6l48a8yMLxDksMX6SP8SSdU6koup83S5ldYDHQ0x8BQ130_provenance.